Can topical ivermectin be used to treat tinea capitis (ringworm of the scalp) in hair?

Topical Ivermectin for Tinea Capitis: Not Recommended

Topical ivermectin should not be used to treat tinea capitis (scalp ringworm) because topical antifungals alone—including ivermectin—cannot penetrate the hair follicle and shaft to eradicate the infection, and oral systemic therapy is mandatory for both clinical and mycological cure. 1

Why Topical Therapy Fails in Tinea Capitis

• Topical agents do not reach the infection site: Dermatophyte fungi invade the hair shaft and follicle deep within the dermis, where topical medications cannot penetrate effectively 2, 3, 4
• Topical therapy alone is explicitly not recommended: The British Association of Dermatologists guidelines (2014) state with Strength of Recommendation A that topical therapy alone should not be used for tinea capitis management 1
• Ivermectin is not indicated for fungal infections: The FDA-approved indications for ivermectin are limited to intestinal strongyloidiasis and onchocerciasis (parasitic worm infections), with no antifungal activity or approval for dermatophyte infections 5

Required Treatment Approach

Oral systemic antifungals are mandatory for tinea capitis to achieve cure and prevent permanent scarring alopecia 1, 6:

First-Line Oral Therapy (Species-Dependent)

For Trichophyton species (T. tonsurans, T. violaceum):

• Terbinafine is first-line 1, 6, 7:
  • <20 kg: 62.5 mg daily for 2–4 weeks
  • 20–40 kg: 125 mg daily for 2–4 weeks

  • 40 kg: 250 mg daily for 2–4 weeks 1, 6

For Microsporum species (M. canis, M. audouinii):

• Griseofulvin is first-line 1, 3:
  • <50 kg: 15–20 mg/kg daily for 6–8 weeks

  • 50 kg: 1 g daily for 6–8 weeks 1, 6

Role of Topical Agents (Adjunctive Only)

• Topical antifungals serve only to reduce spore transmission, not to cure the infection 1, 2
• Adjunctive topical shampoos that may reduce transmission include ketoconazole 2%, selenium sulfide 1%, or povidone-iodine 1, 6
• These are used in addition to—never instead of—oral therapy 2, 3

When to Start Treatment

Initiate oral antifungal therapy immediately when any of the following are present 1, 6:

• Kerion (painful, boggy inflammatory scalp mass with pustules)
• The clinical triad of scaling + lymphadenopathy + any alopecia
• Strong clinical suspicion in high-risk populations (waiting 2–4 weeks for culture results increases transmission and scarring risk) 6

Critical Pitfalls to Avoid

• Do not use topical ivermectin or any topical antifungal as monotherapy—this will result in treatment failure and potential permanent scarring alopecia 1, 2
• Do not confuse ivermectin's antiparasitic activity with antifungal activity—it has no role in fungal infections 5
• Do not delay systemic treatment in clinically obvious cases while awaiting culture confirmation, as this increases transmission and risk of scarring 1, 6
• Confirm mycological cure with repeat cultures, not just clinical improvement, as the endpoint of treatment is mycological clearance 1